Inside AIxBio: Strategic Positioning of AI-first Biotech Ventures

​Join leaders from Owkin, Insilico, Recursion, and Third Rock Ventures to explore the critical elements of building impactful AI-driven biotech ventures, moving beyond model-building to define strong growth strategies that generate long-term value. Our incredible panelists will share candid insights on how successful AI-first and AI-enabled biotech start-ups establish a defensible market edge in a rapidly evolving field. If you're interested in starting an AI-driven biotech company or incorporating AI into your start-up, don't miss this conversation.

​Panelists:

• ​Michelle Chen, PhD: Chief Business Officer Insilico Medicine

• ​Aaron Arvey, Former Head of Computational Discovery, Third Rock Ventures

• ​Jean-Frederic Petit-Nevard: Chief of BD, Owkin

• ​Fatme Dahcheh, PhD: Associate Director of BD, Recursion

​This conversation will be moderated by Michael Retchin.